Crescent Biopharma, Inc. (NASDAQ:CBIO) IPO
IPO
Went public as GLYCOMIMETICS INC. Priced at US$8.00 a share on Jan 9, 2014.
- Price
- US$8.00 a share
- Shares offered
- 7,000,000 shares of common stock
- Offering size
- US$56 million
- Underwriters' option
- Up to 1,050,000 more shares
- Underwriters
- Jefferies, Barclays, Stifel, Canaccord Genuity · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 21, 2013 |
| Filed publicly | Oct 4, 2013 |
| Amended 4 times | Newest Jan 7, 2014 |
| Shares registered with an exchange | Nov 5, 2013 |
| Declared effective by the SEC | Jan 9, 2014 |
| Final prospectus, with the price | Jan 10, 2014 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Jan 10, 2014 |
| EFFECT · Notice that a registration is effective | Jan 9, 2014 |
| CORRESP · Letter to the SEC | Jan 7, 2014 |
| S-1/A · Registration statement, amended | Jan 7, 2014 |
| CORRESP · Letter to the SEC | Jan 6, 2014 |
| S-1/A · Registration statement, amended | Dec 20, 2013 |
| CERTNAS · Nasdaq's certificate of listing | Nov 7, 2013 |
| FWP · Free writing prospectus | Nov 7, 2013 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 5, 2013 |
| CORRESP · Letter to the SEC | Nov 5, 2013 |
| CORRESP · Letter to the SEC | Nov 5, 2013 |
| S-1/A · Registration statement, amended | Oct 31, 2013 |
| S-1/A · Registration statement, amended | Oct 28, 2013 |
| CORRESP · Letter to the SEC | Oct 23, 2013 |
| CORRESP · Letter to the SEC | Oct 18, 2013 |
| UPLOAD · Letter from the SEC | Oct 17, 2013 |
| S-1 · Registration statement | Oct 4, 2013 |
| UPLOAD · Letter from the SEC | Sep 19, 2013 |
| DRS · Draft registration statement | Aug 21, 2013 |
From the cover of the final prospectus (424B4) filed Jan 10, 2014